CAS: 4605-14-5; N1,N1'-(Propane-1,3-Diyl)Bis(Propane-1,3-Diamine)

上下游产品

CAS号35514-00-2 N1,N3-bis(2-cya... | CAS号503-29-7 氮杂环丁烷 | CAS号56-18-8 3,3'-二氨基二丙胺 | CAS号477808-24-5 3,9-dioxo-4,8-d... | CAS号109-76-2 1,3-丙二胺 | CAS号129157-76-2 N1-(3-(azetidin... | CAS号109-64-8 1,3-二溴丙烷 | CAS号54262-75-8 1-氮杂丁烷丙胺 | CAS号110-95-2 四甲基丙二胺

📜N1,N3-Bis(2-Cyanoethyl)Propane-1,3-Diamine置于w-2 Raney Ni 氨,氢气体系中,用 甲醇 作为反应溶剂,化学反应 65.0H,以67%的收率获得产物n,N'-双(3-氨丙基)-1,3-丙二胺
参考文献:Dna结合和基因传递的聚胺-聚乙二醇构建体的合成和表征.
标题:Dna结合和基因传递的聚胺-聚乙二醇构建体的合成和表征.
摘要:需要改进的非病毒载体系统,以在基因治疗中有效地将dna传递至靶细胞核.通过适当的boc保护的嘧啶衍生物与ω-甲氧基peg环氧乙烷基甲基醚的反应合成了一系列线性多胺聚(乙二醇)(peg)构建体.通过这种方法已经制备了带有1-3个meopeg单元和0,2或4个n-甲基的构建体.h2N(ch2)3Nboc(ch2)3Nboc(ch2)3Nhboc是通过在一个锅中通过三氟乙酰基除草剂,Boc的连接以及去除三氟乙酰基而有效制备的.类似的过程得到h 2 N(ch 2)3 Nboc(ch 2)3 Nboc(ch 2)3 Nh 2.用1,3-二溴丙烷将bocmen(ch2)3Nhme烷基化,得到bocmen(ch2)3Nme(ch2)3Nme(ch2)3Nmeboc.氰基乙基化/还原序列扩展了h2N(ch2)3Nboc(ch2)3Nboc(ch2)3Nh2,得到h2N(ch2)3Nboc(ch2)3Nbo
DOI:10.1016/s0968-0896(00)00113-9

专利信息

专利号:US-12303865-B2
优先权日:2022-10-10
标 题 :Aqueous manufacture of aminated MOF complexes
发明人：GOSSELIN AERI; GAMORAS JOEL H; HERM ZOEY ROSE; MCDONALD THOMAS M; WENZ GRAHAM B; ZHU LINA
权利人:MOSAIC MAT INC
摘要:This disclosure relates to a select class of porous adsorbent, metal-organic frameworks (MOFs) capable of adsorbing carbon dioxide, their manufacturing, applications, and methods of use. Specifically, this disclosure relates to the solvo(hydro)thermal synthesis of a family of metal-organic frameworks, and their subsequent processing and transformation into material forms suitable for use in acid gas separations. More specifically, this disclosure relates to the preparation and recovery of MOFs at multiple scales of production, demonstrating the suitability and robustness of the materials thus obtained by the disclosed synthetic route and post-synthetic manipulation employed to tailor the materials for use in a variety of commercial acid gas separation systems, with improved performances, recyclability, and reuse characteristics.

专利号:US-2005085555-A1
优先权日:1997-08-21
标 题:Composition, synthesis and therapeutic applications of polyamines
发明人：MURPHY MICHAEL A; MALACHOWSKI MITCHELL R
摘要:This invention relates to a process of synthesis and composition of open chain (ring), closed ring, linear branched and or substituted polyamines, polyamine derived tyrosine phosphatase inhibitors and PPAR partial agonists/partial antagonists via a series of substitution reactions and optimizing the bioavailability and biological activities of the compounds. Polyamines prevent the toxicty of neutoxins and diabetogenic toxins including paraquat, methyphenyl pyridine radical, rotenone, diazoxide, streptozotocin and alloxan. These polyamines can be to treat neurological, cardiovascular, endocrine acquired and inherited mitochondrial DNA damage diseases and other disorders in mammalian subjects, and more specifically to the therapy of Parkinson's disease, Alzheimer's disease, Lou Gehrig's disease, Binswanger's disease, Olivopontine Cerebellar Degeneration, Lewy Body disease, Diabetes, Stroke, Atherosclerosis, Myocardial Ischemia, Cardiomyopathy, Nephropathy, Ischemia, Glaucoma, Presbycussis, Cancer, Osteoporosis, Rheumatoid Arthritis, Inflammatory Bowel Disease, Multiple Sclerosis and as Antidotes to Toxin Exposure.

专利号:US-2014057877-A1
优先权日:2002-12-18
标题:Therapeutic polyamine compositions and their synthesis
发明人：MURPHY MICHAEL A; MALACHOWSKI MITCHELL R
权利人:MURPHY MICHAEL A; MALACHOWSKI MITCHELL R
摘要:This invention relates to a process of synthesis and composition of open chain (ring), closed ring, linear branched and or substituted polyamines, polyamine derived tyrosine phosphatase inhibitors and PPAR partial agonists/partial antagonists via a series of substitution reactions and optimizing the bioavailability and biological activities of the compounds. Polyamines prevent the toxicity of neurotoxins and diabetogenic toxins including paraquat, methyphenyl pyridine radical, rotenone, diazoxide, streptozotocin and alloxan. These polyamines can be utilized to treat neurological, cardiovascular, endocrine acquired and inherited mitochondrial DNA damage diseases and other disorders in mammalian subjects, and more specifically to the therapy of Parkinson's disease, Alzheimer's disease, Lou Gehrig's disease, Binswanger's disease, Olivopontine Cerebellar Degeneration, Lewy Body disease, Diabetes, Stroke, Atherosclerosis, Myocardial Ischemia, Cardiomyopathy, Nephropathy, Ischemia, Glaucoma, Presbycussis, Cancer, Osteoporosis, Rheumatoid Arthritis, Inflammatory Bowel Disease, Multiple Sclerosis and as Antidotes to Toxin Exposure.

专利号:US-2013102730-A1
优先权日:2010-04-02
标 题:Polyamine-containing polymers and methods of synthesis and use
发明人：JOST ROBERT W; ULUDAG HASAN; BOLUK MEHMET YAMAN
权利人:JOST ROBERT W; ULUDAG HASAN; BOLUK MEHMET YAMAN; ALBERTA INNOVATES TECHNOLOGY FUTURES
摘要:The present invention relates to polyamine-containing polymers and methods of their synthesis and use. The polymer may be hydroxyethylcellulose, dextran, poly(vinyl alcohol) or poly(methyl acrylate).

专利号:DE-102005032795-A1
优先权日:2005-07-14
标 题 :Synthesis of porous manganese oxides

专利号:WO-2007006585-A2
优先权日:2005-07-14
标 题:Synthesis of a porous and/or stratified structure manganese oxide